Inrig Jula bought TVTX
December 24, 2025 · Form 4 insider transaction
Inrig Jula bought 15,000 shares of Travere Therapeutics, Inc. at $8.93 per share, a transaction worth $133.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$8.93
Total value
$133.9K
InsiderInrig Jula
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 24, 2025
Filing dateDecember 29, 2025
Shares owned after103,787
OwnershipDirect
10b5-1 planNo
AmendedNo